Renovaro (FRA:2Q5) Current Deferred Taxes Liabilities : €0.00 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Renovaro Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Renovaro's current deferred tax liabilities for the quarter that ended in Mar. 2024 was €0.00 Mil.

Renovaro Current Deferred Taxes Liabilities Historical Data

The historical data trend for Renovaro's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renovaro Current Deferred Taxes Liabilities Chart

Renovaro Annual Data

Trend

Mar13

Dec14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Current Deferred Taxes Liabilities

Get a 7-Day Free Trial

Renovaro Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Deferred Taxes Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Renovaro Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Renovaro's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Renovaro (FRA:2Q5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Renovaro Inc (FRA:2Q5) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

RENB:USA 2Q5:Germany

Address

2080 Century Park East, Suite 906, Los Angeles, CA, USA, 90067

Website

https://www.enochianbio.com

Renovaro Biosciences Inc Formerly Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of HIV, HBV, and cancer with the intent to manufacture said products.

Renovaro (FRA:2Q5) Headlines

No Headlines